Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice

被引:46
|
作者
Lieberman, Jay R. [1 ]
Heckmann, Nathanael [1 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90033 USA
关键词
MOLECULAR-WEIGHT HEPARIN; CLINICAL-PRACTICE GUIDELINES; MOBILE COMPRESSION DEVICE; DOUBLE-BLIND TRIAL; ELECTIVE HIP; DABIGATRAN ETEXILATE; RANDOMIZED-TRIAL; POSTOPERATIVE FONDAPARINUX; THROMBOSIS PREVENTION; RISK STRATIFICATION;
D O I
10.5435/JAAOS-D-15-00760
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Venous thromboembolism (VTE) prophylaxis is recommended for all patients undergoing total hip arthroplasty or total knee arthroplasty. The selection of an appropriate prophylaxis regimen represents a balance between efficacy and safety. To help orthopaedic surgeons select an appropriate VTE prophylaxis regimen for their patients, the American Academy of Orthopaedic Surgeons and the American College of Chest Physicians have developed guidelines. These guidelines do not recommend an optimal regimen, however. Rather, an individualized prophylaxis regimen that balances efficacy and safety is recommended for each patient, based on various risk factors. Because of a paucity of data and a lack of adequately powered head-to-head trials, implementing these guidelines can be challenging for the orthopaedic surgeon. Knowledge of the prophylaxis options and the VTE risk factors is paramount for developing an effective VTE prophylaxis algorithm for the surgeon's practice.
引用
收藏
页码:789 / 798
页数:10
相关论文
共 50 条